Spruce Street Capital LP
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 2050194
NEW YORK, NY
Position in KNSA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$58,710,576
+$22,065,393 QoQ
Shares Held
918,070
+20.6% QoQ
Ownership
0.588%
of shares outstanding
% of Portfolio
11.52%
of 13F equity value
Holder Rank
#10
of 266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Spruce Street Capital LP holds $87,209,678 across 2 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (67.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
918,070 | $58,710,576 | |
| 2 | ALKS |
Alkermes plc.
|
543,876 | $28,499,102 |
All Filings in KNSA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,710,576 | 918,070 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $36,645,183 | 761,063 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $17,943,007 | 434,982 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||